{"title":"Wound Treatment","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e The Wound Treatment collection at EMIS Asia offers a curated range of advanced wound care products including foams, alginates, hydrocolloids, hydrofibers, and antimicrobial dressings for Singapore healthcare professionals and home care providers. Products are selected for compliance with CE MDR 2017\/745 and ISO 13485:2016 quality management standards, meeting the clinical demands of acute and chronic wound management across Singapore hospitals, polyclinics, and community nursing settings. This buyer's guide assists clinicians and procurement teams in selecting the appropriate dressing modality based on wound type, exudate level, infection status, and care setting.\u003c\/div\u003e\n\u003ch2\u003eWound Treatment Product Overview\u003c\/h2\u003e\n\u003cp\u003eOptimal wound management requires matching the dressing to the wound's biological state and exudate profile at each phase of healing. The proliferative and remodelling phases of wound healing depend on a moist, thermally stable, and microbiologically controlled wound environment — a principle established by Winter (1962) and now codified in evidence-based guidelines from the European Wound Management Association (EWMA) and the World Union of Wound Healing Societies (WUWHS). Selecting the correct dressing category reduces healing time, lowers infection risk, minimises patient discomfort, and controls overall care costs.\u003c\/p\u003e\n\u003cp\u003eEMIS Asia stocks advanced interactive and bioactive wound dressings used across Singapore's acute hospitals, community health facilities, home care agencies, and specialist wound care clinics. All products in this collection meet CE marking requirements under EU MDR 2017\/745, and are supplied through validated documentation processes to support Health Sciences Authority (HSA) Singapore procurement compliance and Ministry of Health (MOH) institutional purchasing frameworks.\u003c\/p\u003e\n\u003ch2\u003eWound Dressing Selection Guide\u003c\/h2\u003e\n\u003ctable style=\"border-collapse: collapse; width: 100%;\" cellspacing=\"0\" cellpadding=\"8\" border=\"1\"\u003e\n\u003cthead style=\"background: #e8f0fe;\"\u003e\n\u003ctr\u003e\n\u003cth\u003eWound Type \/ Condition\u003c\/th\u003e\n\u003cth\u003eExudate Level\u003c\/th\u003e\n\u003cth\u003eRecommended Dressing Category\u003c\/th\u003e\n\u003cth\u003eClinical Rationale\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVenous leg ulcer (clean)\u003c\/td\u003e\n\u003ctd\u003eModerate–Heavy\u003c\/td\u003e\n\u003ctd\u003eFoam or Hydrofiber\u003c\/td\u003e\n\u003ctd\u003eHigh absorbency prevents periwound maceration; maintains moist healing environment per EWMA guidelines\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiabetic foot ulcer (infected)\u003c\/td\u003e\n\u003ctd\u003eModerate–Heavy\u003c\/td\u003e\n\u003ctd\u003eAlginate Silver \/ Antimicrobial foam\u003c\/td\u003e\n\u003ctd\u003eIonic silver delivers broad-spectrum antimicrobial action including MRSA; alginate manages exudate and fills cavity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePressure injury Stage 2–4\u003c\/td\u003e\n\u003ctd\u003eLow–Moderate\u003c\/td\u003e\n\u003ctd\u003eHydrocolloid or Foam\u003c\/td\u003e\n\u003ctd\u003eConforms to body contours; facilitates autolytic debridement; reduces shear forces at bony prominences\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePost-surgical \/ acute wound\u003c\/td\u003e\n\u003ctd\u003eLow–Moderate\u003c\/td\u003e\n\u003ctd\u003eFilm dressing or Non-adherent pad\u003c\/td\u003e\n\u003ctd\u003eTransparent film allows visual inspection without dressing removal; maintains sterile environment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePartial-thickness burn\u003c\/td\u003e\n\u003ctd\u003eModerate–Heavy\u003c\/td\u003e\n\u003ctd\u003eAlginate Silver or Hydrofiber\u003c\/td\u003e\n\u003ctd\u003eHaemostatic and antimicrobial properties; supports re-epithelialisation; recommended by British Burns Association (BBA)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCavity wound \/ sinus tract\u003c\/td\u003e\n\u003ctd\u003eModerate–Heavy\u003c\/td\u003e\n\u003ctd\u003eAlginate rope or Hydrofiber rope\u003c\/td\u003e\n\u003ctd\u003eConformable fiber fills dead space and wicks exudate; prevents premature surface closure over cavity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSloughy\/necrotic wound\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003eHydrogel under secondary dressing\u003c\/td\u003e\n\u003ctd\u003eRehydrates necrotic tissue; facilitates autolytic debridement; avoids sharp debridement in community settings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications for Advanced Wound Dressings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic non-healing wounds:\u003c\/strong\u003e Venous, arterial, and mixed-aetiology leg ulcers requiring moist wound healing and exudate management over extended treatment periods in Singapore's ageing population\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiabetic foot ulcers (DFU):\u003c\/strong\u003e Neuropathic or ischaemic ulcers with moderate-to-heavy exudate and elevated infection risk; Singapore has one of Asia's highest diabetes prevalence rates, driving demand for advanced DFU dressings\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePressure injuries (Stage 2–4):\u003c\/strong\u003e Skin breakdown in immobile patients requiring absorbent, low-trauma dressings that reduce shear and friction at bony prominences\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-operative wounds:\u003c\/strong\u003e Surgical incisions, dehisced wounds, and drain sites requiring sterile secondary coverage and exudate containment in both acute and home care settings\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePartial-thickness burns and donor sites:\u003c\/strong\u003e Thermal injuries requiring moist, antimicrobial coverage to support re-epithelialisation and minimise scarring\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFungating tumour wounds:\u003c\/strong\u003e Malignant wounds requiring odour management, high absorbency, and atraumatic dressing removal in palliative care contexts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How do I select between foam, alginate, and hydrocolloid dressings for the same patient?\u003c\/strong\u003e\u003cbr\u003eA: Selection is governed primarily by exudate volume and wound infection status. Foam dressings are preferred for moderate-to-heavy non-infected exudate; alginates (with or without silver) for infected or heavily exuding wounds requiring haemostatic properties; hydrocolloids for low-to-moderate exudate wounds needing autolytic debridement. The EWMA TIME framework — Tissue, Infection, Moisture, Edge — provides a validated decision-making model applicable across wound types.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: When is an antimicrobial dressing clinically indicated versus a standard dressing?\u003c\/strong\u003e\u003cbr\u003eA: Antimicrobial dressings (silver, iodine, or PHMB-based) are indicated when two or more clinical signs of localised infection are present: erythema, warmth, oedema, purulent exudate, or increased pain at the wound site. They are also appropriate for wounds with high biofilm risk, including chronic wounds not progressing despite optimised local and systemic management over 2–4 weeks.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the recommended dressing change frequency for advanced wound dressings?\u003c\/strong\u003e\u003cbr\u003eA: Change frequency depends on exudate level and dressing capacity. Foam dressings may remain in place 3–7 days if not saturated; alginates are changed when fully converted to gel (typically every 1–3 days for high-exudate wounds); hydrocolloids can remain up to 7 days. Always change earlier if leakage, periwound maceration, or clinical deterioration occurs.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Are EMIS Asia wound care products compliant with Singapore healthcare procurement requirements?\u003c\/strong\u003e\u003cbr\u003eA: Products in the EMIS Asia wound treatment catalogue carry CE marking under EU MDR 2017\/745 and comply with ISO 13485:2016 quality management requirements. Institutions subject to HSA Singapore or MOH procurement frameworks can request product technical files, Declaration of Conformity documents, and batch traceability records on request. EMIS Asia supports institutional formulary listing processes for Singapore public and private healthcare groups.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can wound dressings be purchased for home care use in Singapore?\u003c\/strong\u003e\u003cbr\u003eA: Yes. EMIS Asia supplies both institutional and home care clients in Singapore. Dressings can be prescribed through general practitioners, wound care nurses, community nurses, or specialist clinics. Correct dressing selection, application guidance, and change frequency protocols are available through EMIS Asia's clinical support team for patients transitioning from acute to home care settings.\u003c\/p\u003e","products":[{"product_id":"principelle-if-ointment-medical-grade-honey-based","title":"Principelle If Ointment Medical Grade Honey Based 10g","description":"\u003cp\u003e\u0026lt;head\u0026gt;\u0026lt;meta charset=\"UTF-8\" \/\u0026gt;\u0026lt;\/head\u0026gt;\u003c\/p\u003e\n\u003cp\u003ePrincipelle IF® is a sterile wound dressing, comprising an inert acetate substrate impregnated with an ointment containing a blend of trace elements and medical grade honey. The formulation for dressings contains no synthetic components. Minerals, trace elements, and oxides are directly blended with medical grade dark buckwheat honey.\u003c\/p\u003e\n\u003cp\u003ePrincipelle IF® medical grade honey wound dressing is indicated for the treatment of acute and chronic wounds, including contaminated and infected wounds. It may be used on moderatelyexuding, lightly exuding and dry wounds. With a suitable secondary dressing it can also be used on heavily exuding wounds. Depending on the wound type it may be covered by traditional dressings, a special film dressing, a foam or alginate dressing, or Principelle Matrix.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is Principelle If Ointment Medical Grade Honey Based 10g used for?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Principelle If Ointment Medical Grade Honey Based 10g by Principelle is a advanced wound dressing used for wound management. It is designed to support moist wound healing, manage exudate, and protect the wound bed from contamination. It is commonly used in Singapore hospitals and home care settings for chronic wounds, post-surgical wounds, and ulcers. Always follow the guidance of your wound care nurse or doctor when selecting a dressing.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How often should Principelle If Ointment Medical Grade Honey Based 10g be changed?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Principelle If Ointment Medical Grade Honey Based 10g should generally be changed every 1–7 days depending on wound type and exudate. However, frequency should always be guided by your wound care nurse or clinician based on wound size, exudate level, and signs of infection. Do not leave any dressing in place if it becomes saturated, dislodged, or if the wound shows signs of infection such as increased redness, warmth, or discharge.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Principelle If Ointment Medical Grade Honey Based 10g available without prescription in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes, Principelle If Ointment Medical Grade Honey Based 10g is available for purchase from EMIS+ (emis.asia) without a prescription for general wound care use. For complex or chronic wounds, we strongly recommend consulting a wound care nurse, GP, or specialist at a Singapore hospital such as SGH, NUH, TTSH, or CGH before selecting a dressing. EMIS+ nurses can also provide product guidance — contact us at emis.asia\/pages\/contact.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Principelle If Ointment Medical Grade Honey Based 10g in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Principelle If Ointment Medical Grade Honey Based 10g is available from EMIS+ at emis.asia, Singapore's nurse-led medical supply store. We offer fast island-wide delivery, competitive pricing, and bulk ordering for healthcare facilities and home care users. Visit emis.asia or contact our team for assistance.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"Principelle","offers":[{"title":"Default Title","offer_id":41671974617166,"sku":"","price":37.0,"currency_code":"SGD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/Principelle_IF_Ointment.png?v=1753975659"},{"product_id":"octenilin-irrigation-solution-350ml","title":"Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Octenilin Wound Irrigation Solution by Schülke is a sterile, ready-to-use wound cleansing solution containing octenidine dihydrochloride as a preservative with antimicrobial properties. Its low surface tension enables effective penetration into wound fissures and cavities to facilitate mechanical removal of biofilm, fibrinous deposits, and necrotic debris. Indicated for moistening, irrigating, and cleansing acute and chronic wounds in clinical and home-care settings.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eOctenilin Wound Irrigation Solution is a sterile aqueous formulation developed by Schülke \u0026amp; Mayr GmbH for the cleansing, moistening, and decontamination of acute and chronic skin wounds. The solution contains octenidine dihydrochloride, ethylhexylglycerin, and glycerol in highly purified water, producing a low surface tension that enables thorough penetration into wound fissures, undermined edges, and deep cavities where standard saline irrigation may be insufficient.\u003c\/p\u003e\n\u003cp\u003eThe solution mechanically removes wound biofilm, fibrinous coatings, and loosely adherent necrotic tissue without cytotoxic effects on healthy granulation tissue. Octenilin is colourless, odourless, and pH-neutral, making it well tolerated across a broad patient population including paediatric and geriatric patients. It is compatible with Negative Pressure Wound Therapy (NPWT) systems including the V.A.C. Ulta platform (KCI\/3M), and can be used to moisten wound pads and dressings prior to application or removal.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eManufacturer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSchülke \u0026amp; Mayr GmbH (Germany)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eoctenilin® Wound Irrigation Solution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eVolume\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e350 ml\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eActive Preservative\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOctenidine dihydrochloride (octenidine HCl)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eComposition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAqua valde purificata, glycerol, ethylhexylglycerin, octenidine HCl\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSterility\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile, sealed; use within 8 weeks of first opening\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003epH\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNeutral\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLatex Content\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLatex-free\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCE marked Class IIb Medical Device per EU MDR 2017\/745; ISO 13485 certified manufacturing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e350 ml squeeze bottle, individually sealed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eIrrigation and cleansing of acute traumatic wounds, surgical incision sites, and skin graft donor sites\u003c\/li\u003e\n\u003cli\u003eManagement of chronic wounds including venous leg ulcers, diabetic foot ulcers, and pressure injuries (Stage II–IV)\u003c\/li\u003e\n\u003cli\u003eMechanical removal of wound biofilm and fibrinous deposits in non-healing wounds\u003c\/li\u003e\n\u003cli\u003eMoistening and loosening of adherent or dried wound dressings prior to removal to minimise patient discomfort\u003c\/li\u003e\n\u003cli\u003eWound bed preparation in conjunction with Negative Pressure Wound Therapy (NPWT) protocols\u003c\/li\u003e\n\u003cli\u003eIrrigation of wound fissures, tunnelling, and deep cavities where standard rinsing is insufficient\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does octenilin differ from standard normal saline wound irrigation?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Unlike 0.9% sodium chloride, octenilin contains octenidine HCl as a preservative and ethylhexylglycerin, which together produce a significantly lower surface tension. This allows the solution to penetrate biofilm matrices and deep wound recesses more effectively than saline alone. The European Wound Management Association (EWMA) position document on wound cleansing supports the use of surfactant-containing solutions for biofilm-compromised wounds.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is octenilin safe for long-term use on chronic wounds?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. Octenilin is colourless, odourless, pH-neutral, and has demonstrated good tissue compatibility in clinical evaluations. It does not contain alcohol, iodine, or chlorhexidine, reducing the risk of cytotoxicity to healthy granulation tissue during prolonged treatment courses.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can octenilin be used with Negative Pressure Wound Therapy (NPWT)?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. Schülke confirms compatibility with NPWT systems including the KCI\/3M V.A.C. Ulta platform. The solution can be instilled into the wound bed as part of NPWTi-d (instillation and dwell therapy) protocols at clinician discretion.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the shelf life after opening?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Once the sterile seal is broken, octenilin should be used within 8 weeks. The unopened product has a shelf life as indicated on the packaging. Store at room temperature and protect from direct sunlight.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is octenilin available for purchase in Singapore?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Yes. Octenilin Wound Irrigation Solution is available through EMIS (Essential Medical International Supplies Pte Ltd) in Singapore. The product is classified as a Class IIb medical device under the Health Sciences Authority (HSA) regulatory framework and may be purchased by healthcare professionals, clinics, and hospitals for institutional wound care protocols.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution used for?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution by Schulke is a advanced wound dressing used for wound management. It is designed to support moist wound healing, manage exudate, and protect the wound bed from contamination. It is commonly used in Singapore hospitals and home care settings for chronic wounds, post-surgical wounds, and ulcers. Always follow the guidance of your wound care nurse or doctor when selecting a dressing.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How often should Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution be changed?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution should generally be changed every 1–7 days depending on wound type and exudate. However, frequency should always be guided by your wound care nurse or clinician based on wound size, exudate level, and signs of infection. Do not leave any dressing in place if it becomes saturated, dislodged, or if the wound shows signs of infection such as increased redness, warmth, or discharge.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution available without prescription in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes, Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution is available for purchase from EMIS+ (emis.asia) without a prescription for general wound care use. For complex or chronic wounds, we strongly recommend consulting a wound care nurse, GP, or specialist at a Singapore hospital such as SGH, NUH, TTSH, or CGH before selecting a dressing. EMIS+ nurses can also provide product guidance — contact us at emis.asia\/pages\/contact.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Schulke Octenilin Irrigation Solution 350ml Sterile Wound Cleansing Solution is available from EMIS+ at emis.asia, Singapore's nurse-led medical supply store. We offer fast island-wide delivery, competitive pricing, and bulk ordering for healthcare facilities and home care users. Visit emis.asia or contact our team for assistance.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"Schulke","offers":[{"title":"Default Title","offer_id":43229625778254,"sku":null,"price":33.85,"currency_code":"SGD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/Schulke_Octenilin_Irrigation_Solution.png?v=1767040629"},{"product_id":"granulox-topical-haemoglobin-spray","title":"360001 Granulox Topical Haemoglobin Spray 12ml","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Granulox® (REF 360001) is a topical haemoglobin spray manufactured by Mölnlycke Health Care AB, classified as a Class III CE-marked medical device under EU MDR 2017\/745, indicated as adjunct therapy for chronic hard-to-heal wounds including diabetic foot ulcers, venous and arterial leg ulcers, pressure injuries, and post-surgical wounds. The spray delivers highly purified porcine haemoglobin directly to the wound bed, where it binds ambient oxygen and releases it via facilitated diffusion into hypoxic wound tissue, correcting localised oxygen deficits that impede cellular proliferation and granulation. A 2018 meta-analysis of pooled cohort data (PMID: 29988544) demonstrated statistically significant improvements in healing rates across diabetic foot ulcers (p=0.01), venous leg ulcers (p=0.04), traumatic wounds (p\u0026lt;0.001), burns (p=0.02), and post-surgical wounds (p=0.001) when Granulox® was added to standard wound care.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eGranulox® Topical Haemoglobin Spray is an oxygenating adjunct therapy developed to address tissue hypoxia in chronic, stalled wounds. Wound hypoxia — defined as a partial pressure of oxygen below 20 mmHg in the wound bed — suppresses fibroblast proliferation, keratinocyte migration, collagen synthesis, and neutrophil bactericidal activity, resulting in non-healing or slowly healing wounds. Granulox® corrects this deficit by delivering a thin film of highly purified porcine haemoglobin onto the wound surface; the haemoglobin then binds oxygen from ambient air and releases it via simplified (facilitated) diffusion into the underlying wound tissue, mimicking the physiological role of erythrocyte haemoglobin in oxygen transport.\u003c\/p\u003e\n\u003cp\u003eEMIS Singapore supplies Granulox® 12 ml (REF 360001) for clinical procurement by hospitals, specialist wound care clinics, community health teams, and home care providers across Singapore. The product is compatible with all breathable, non-occlusive secondary dressings and is applied before dressing placement. The 12 ml bottle delivers approximately 200 spray actuations, sufficient for multiple dressing changes over a standard 13-week treatment course. A Singapore-specific case series published in the \u003cem\u003eInternational Wound Journal\u003c\/em\u003e (PMID: 32349571) documented complete or near-complete healing in patients with refractory venous leg ulcers and diabetic foot ulcers following adjunct use of Granulox®.\u003c\/p\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003ctable style=\"width: 100%; border-collapse: collapse; font-size: 14px;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold; width: 35%;\"\u003eManufacturer\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eMölnlycke Health Care AB, Gothenburg, Sweden\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eProduct Name\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eGranulox® Topical Haemoglobin Spray\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eREF \/ Product Code\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003e360001\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eActive Ingredient\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eHighly purified porcine haemoglobin (spray solution)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eVolume per Bottle\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003e12 ml (~200 actuations)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eDevice Classification\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eClass III Medical Device — EU MDR 2017\/745 CE-marked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eRegulatory Clearance\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eCE Mark (EU MDR 2017\/745); HSA-registered medical device, Singapore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eApplication Method\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eSpray 1–2 actuations per 10 cm² wound area onto wound bed; cover with breathable non-occlusive secondary dressing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eDosing Frequency\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eMinimum twice weekly; at each dressing change\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eWound Compatibility\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eModerate to heavily exuding chronic wounds; not for occlusive dressing use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"background: #f0f4f8;\"\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eStorage\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eStore below 25°C; protect from direct sunlight; do not freeze\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd; font-weight: bold;\"\u003eQuality Standard\u003c\/td\u003e\n\u003ctd style=\"padding: 8px 12px; border: 1px solid #ddd;\"\u003eManufactured under ISO 13485:2016 quality management system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiabetic foot ulcers (DFU):\u003c\/strong\u003e Adjunct to standard offloading, debridement, and moist wound care in neuropathic or neuroischaemic DFUs with stalled healing; aligned with IWGDF 2023 guidance on topical oxygen therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVenous leg ulcers (VLU):\u003c\/strong\u003e Used alongside compression bandaging per Singapore MOH clinical practice guidelines; a randomised controlled trial demonstrated 53% wound size reduction vs. 21% increase in standard care at 13 weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eArterial and mixed-aetiology leg ulcers:\u003c\/strong\u003e Applied as adjunct where underlying ischaemia limits tissue oxygen delivery; requires concurrent vascular assessment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePressure injuries (Stage III–IV):\u003c\/strong\u003e Indicated for hypoxic pressure injuries in immobile or palliative patients with recalcitrant wound beds; applied prior to foam or hydrofibre secondary dressings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-surgical dehisced wounds:\u003c\/strong\u003e Accelerates secondary intention healing in surgical site dehiscence; pooled cohort evidence (PMID: 29988544, p=0.001) supports use in this wound category.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBurn wounds (partial thickness):\u003c\/strong\u003e Adjunct to moist wound care in partial-thickness burns to support re-epithelialisation; clinical benefit demonstrated in pooled meta-analysis data.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is the mechanism by which Granulox® delivers oxygen to wound tissue?\u003c\/h3\u003e\n\u003cp\u003eGranulox® contains highly purified porcine haemoglobin suspended in a spray solution. When applied to the wound bed, the haemoglobin film binds molecular oxygen from ambient air at the wound surface (partial pressure ~21 kPa) and releases it by facilitated diffusion into the hypoxic wound tissue below (partial pressure typically \u0026lt;3 kPa in chronic wounds). This mimics the physiological oxygen-carrying function of red blood cells without requiring a vascular delivery route, making it effective in ischaemic or poorly vascularised wound beds where systemic oxygen delivery is insufficient.\u003c\/p\u003e\n\u003ch3\u003eHow does Granulox® interact with different secondary wound dressings?\u003c\/h3\u003e\n\u003cp\u003eGranulox® must be used with breathable, non-occlusive secondary dressings that allow ambient air to reach the haemoglobin film. Compatible dressings include foam dressings (e.g., Mepilex®, Allevyn®), alginate dressings, hydrocolloid dressings with perforations, and non-woven contact layers. Occlusive film dressings (e.g., transparent adhesive films applied as a sole dressing) should not be used as secondary covers, as they block the oxygen supply required for haemoglobin saturation. Granulox® is applied first, directly onto the wound bed, then covered with the chosen secondary dressing.\u003c\/p\u003e\n\u003ch3\u003eIs Granulox® suitable for infected wounds, and should antimicrobial dressings be used concurrently?\u003c\/h3\u003e\n\u003cp\u003eGranulox® is not classified as an antimicrobial agent and does not replace debridement or antimicrobial dressings in critically colonised or clinically infected wounds. However, by improving wound oxygenation, it supports neutrophil bactericidal activity — neutrophil oxidative burst requires adequate tissue oxygen. In wounds with critical colonisation or local infection, antimicrobial primary dressings (e.g., silver alginate, DACC-coated, or iodine-based) may be used as the primary contact layer before applying Granulox® spray, subject to clinician assessment. Systemic antibiotics for clinical infection should be managed per Singapore MOH antimicrobial stewardship guidelines.\u003c\/p\u003e\n\u003ch3\u003eWhat clinical evidence supports Granulox® use, and are there Singapore-specific data?\u003c\/h3\u003e\n\u003cp\u003eThe evidence base for Granulox® includes multiple retrospective cohort studies and a 2018 pooled meta-analysis (PMID: 29988544) demonstrating significantly improved healing rates across five wound categories when added to standard care. A Singapore-specific case series (PMID: 32349571, published in the \u003cem\u003eInternational Wound Journal\u003c\/em\u003e) documented outcomes in Singapore patients with venous leg ulcers and diabetic foot ulcers, supporting the product's clinical relevance in the local care setting. The International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines include a conditional recommendation to consider topical oxygen as adjunct therapy for DFUs failing standard care.\u003c\/p\u003e\n\u003ch3\u003eHow do Singapore clinics and home care providers procure Granulox® through EMIS?\u003c\/h3\u003e\n\u003cp\u003eEMIS Singapore (emis.asia) supplies Granulox® REF 360001 to hospitals, specialist wound care clinics, polyclinics, community nursing providers, and home care settings islandwide. Procurement is available via direct B2B order through the EMIS website or by contacting our clinical supply team. HSA-registered medical device importation and distribution requirements are fulfilled by EMIS as the licensed distributor. Repeat orders can be arranged on standing order for institutions with ongoing wound care programmes. Delivery is available island-wide with same-day or next-day options for urgent clinical needs.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is Granulox Topical Haemoglobin Spray 12ml used for?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Granulox Topical Haemoglobin Spray 12ml by Molnlycke is a advanced wound dressing used for wound management. It is designed to support moist wound healing, manage exudate, and protect the wound bed from contamination. It is commonly used in Singapore hospitals and home care settings for chronic wounds, post-surgical wounds, and ulcers. Always follow the guidance of your wound care nurse or doctor when selecting a dressing.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How often should Granulox Topical Haemoglobin Spray 12ml be changed?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Granulox Topical Haemoglobin Spray 12ml should generally be changed every 1–7 days depending on wound type and exudate. However, frequency should always be guided by your wound care nurse or clinician based on wound size, exudate level, and signs of infection. Do not leave any dressing in place if it becomes saturated, dislodged, or if the wound shows signs of infection such as increased redness, warmth, or discharge.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Granulox Topical Haemoglobin Spray 12ml available without prescription in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes, Granulox Topical Haemoglobin Spray 12ml is available for purchase from EMIS+ (emis.asia) without a prescription for general wound care use. For complex or chronic wounds, we strongly recommend consulting a wound care nurse, GP, or specialist at a Singapore hospital such as SGH, NUH, TTSH, or CGH before selecting a dressing. EMIS+ nurses can also provide product guidance — contact us at emis.asia\/pages\/contact.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Granulox Topical Haemoglobin Spray 12ml in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Granulox Topical Haemoglobin Spray 12ml is available from EMIS+ at emis.asia, Singapore's nurse-led medical supply store. We offer fast island-wide delivery, competitive pricing, and bulk ordering for healthcare facilities and home care users. Visit emis.asia or contact our team for assistance.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"Molnlycke","offers":[{"title":"Default Title","offer_id":43302979633230,"sku":"23304909","price":280.0,"currency_code":"SGD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/97_ba0c5482-bbcd-4b0f-9c99-84b942be594c.png?v=1777431589"}],"url":"https:\/\/www.emis.asia\/th-th\/collections\/wound-treatment.oembed","provider":"EMIS+","version":"1.0","type":"link"}